Cargando…
PK/PD modeling to characterize placebo and treatment effect of omalizumab for chronic spontaneous urticaria
The pharmacokinetic (PK) characteristics of omalizumab and its pharmacodynamic (PD) effect in patients has yet to be fully characterized in chronic spontaneous urticaria, which could elucidate its pathogenesis and treatment response. This study has two objectives; (1) characterize the population PK...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272305/ https://www.ncbi.nlm.nih.gov/pubmed/36896910 http://dx.doi.org/10.1002/psp4.12953 |